The dengue vaccine developed by the Takeda laboratory can now be found in pharmacies in the province of Santa Fe. The news was announced by Miriam Monasterolo, president of the College of Pharmacists.
From January of this year to the first week of December, more than 134,000 cases of dengue were recorded in the country, of which more than 125,000 were indigenous, recording the highest number of cases since epidemic years in 2016, 2018 and 2020 with a total of 68 people killed in the north and center of the country.
The vaccine, approved in November, initially had limited availability, generating a significant increase in visits to local pharmacies. Monasterolo explained to El Litoral that, “although the approval was granted in November, the available doses were scarce. However, these days, the stock began to arrive at pharmacies.”
The vaccine, approved in November, initially had limited availability.
Anyone interested in purchasing the vaccine can go to pharmacies and check availability. Monasterolo emphasized that, “if stock runs out at a specific pharmacy, they have the option of requesting doses from drugstores to meet growing demand.”
The president of the College of Pharmacists also highlighted that “Takeda’s vaccine is made up of live attenuated viruses. However, due to this characteristic, there is a group of patients who cannot receive it. Those who are interested must present a medical prescription when going to the pharmacy.”
Who can apply it
The vaccine is recommended for people four years of age and older, regardless of whether they previously suffered from dengue. A medical prescription is essential to ensure safe and appropriate use of the vaccine. Monasterolo stressed the importance of having a medical professional evaluate the suitability of the vaccine for each patient before its administration.
The vaccine is used to prevent dengue caused by any of the four existing serotypes of the virus.
Regarding the application regime, the professional provided crucial details. “The vaccine consists of two doses, with the second administered 90 days after the first. Clinical studies demonstrated remarkable efficacy, covering all four dengue serotypes. Furthermore, the adverse effects are minimal, mainly pain at the application site, mild discomfort and headaches,” said the interviewee.
Finally, Monasterolo assured that pharmacists will carry out pharmacovigilance, monitoring any adverse effects once the vaccine begins to be administered to the general population.
How long is the incubation time of dengue?
In most cases, symptoms appear abruptly between 5 and 7 days after the bite (and may be 4 to 10 days later). Abrupt symptomatic onset.
Generally, people begin their symptoms with a febrile phase and it is estimated that 1 in 20 cases will develop a moderate to severe illness.
The symptoms begin with a febrile phase
What are the symptoms
– The symptoms begin with a febrile phase that can last from 2 to 7 days, in addition to that it can be accompanied by intense headaches, retro-ocular pain, myalgias, arthralgias and bones.
They may present macular eruptions and in a smaller percentage petechiae, ecchymosis, epistaxis, and other coagulopathic manifestations.
Dengue should be suspected in any case of nonspecific febrile syndrome defined as:
• Person of any age and sex who presents with fever, lasting less than seven (7) days without affecting the upper airways or other defined etiology, accompanied by two or more of the following signs:
– Headache and/or retroocular pain,
– General malaise, myoarthralgia,
– Leukopenia, plateletopenia, (only if available).
2023-12-25 19:02:44
#Dengue #vaccine #Santa #pharmacies #aimed
